These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 17603934)

  • 1. Effect of nitric oxide and peroxynitrite on type I collagen synthesis in normal and scleroderma dermal fibroblasts.
    Dooley A; Gao B; Shi-Wen X; Abraham DJ; Black CM; Jacobs M; Bruckdorfer KR
    Free Radic Biol Med; 2007 Jul; 43(2):253-64. PubMed ID: 17603934
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation of collagen type I, fibronectin and dermal fibroblast function and activity, in systemic sclerosis by the antioxidant epigallocatechin-3-gallate.
    Dooley A; Shi-Wen X; Aden N; Tranah T; Desai N; Denton CP; Abraham DJ; Bruckdorfer R
    Rheumatology (Oxford); 2010 Nov; 49(11):2024-36. PubMed ID: 20627968
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exogenous nitric oxide enhances the synthesis of type I collagen and heat shock protein 47 by normal human dermal fibroblasts.
    Obayashi K; Akamatsu H; Okano Y; Matsunaga K; Masaki H
    J Dermatol Sci; 2006 Feb; 41(2):121-6. PubMed ID: 16171977
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of systemic sclerosis dermal fibroblast type I collagen production and gene expression by simvastatin.
    Louneva N; Huaman G; Fertala J; Jiménez SA
    Arthritis Rheum; 2006 Apr; 54(4):1298-308. PubMed ID: 16575855
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Minocycline does not alter collagen type I metabolism of dermal fibroblasts in culture.
    Anderegg U; Prieb J; Hildebrandt G; Saalbach A
    Arch Dermatol Res; 2002 May; 294(3):103-8. PubMed ID: 12029495
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systemic sclerosis Th2 cells inhibit collagen production by dermal fibroblasts via membrane-associated tumor necrosis factor alpha.
    Chizzolini C; Parel Y; De Luca C; Tyndall A; Akesson A; Scheja A; Dayer JM
    Arthritis Rheum; 2003 Sep; 48(9):2593-604. PubMed ID: 13130479
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of type I collagen production by dermal fibroblasts upon contact with activated T cells: different sensitivity to inhibition between systemic sclerosis and control fibroblasts.
    Chizzolini C; Rezzonico R; Ribbens C; Burger D; Wollheim FA; Dayer JM
    Arthritis Rheum; 1998 Nov; 41(11):2039-47. PubMed ID: 9811060
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An increased transforming growth factor beta receptor type I:type II ratio contributes to elevated collagen protein synthesis that is resistant to inhibition via a kinase-deficient transforming growth factor beta receptor type II in scleroderma.
    Pannu J; Gore-Hyer E; Yamanaka M; Smith EA; Rubinchik S; Dong JY; Jablonska S; Blaszczyk M; Trojanowska M
    Arthritis Rheum; 2004 May; 50(5):1566-77. PubMed ID: 15146427
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ATX-S10(Na)-PDT shows more potent effect on collagen metabolism of human normal and scleroderma dermal fibroblasts than ALA-PDT.
    Takahashi H; Komatsu S; Ibe M; Ishida-Yamamoto A; Nakajima S; Sakata I; Iizuka H
    Arch Dermatol Res; 2006 Nov; 298(6):257-63. PubMed ID: 16977444
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between enhanced type I collagen expression and epigenetic repression of the FLI1 gene in scleroderma fibroblasts.
    Wang Y; Fan PS; Kahaleh B
    Arthritis Rheum; 2006 Jul; 54(7):2271-9. PubMed ID: 16802366
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased accumulation of extracellular thrombospondin-2 due to low degradation activity stimulates type I collagen expression in scleroderma fibroblasts.
    Kajihara I; Jinnin M; Yamane K; Makino T; Honda N; Igata T; Masuguchi S; Fukushima S; Okamoto Y; Hasegawa M; Fujimoto M; Ihn H
    Am J Pathol; 2012 Feb; 180(2):703-14. PubMed ID: 22142808
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tempol, one of nitroxides, is a novel ultraviolet-A1 radiation protector for human dermal fibroblasts.
    Yan SX; Hong XY; Hu Y; Liao KH
    J Dermatol Sci; 2005 Mar; 37(3):137-43. PubMed ID: 15734282
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased levels of transforming growth factor beta receptor type I and up-regulation of matrix gene program: A model of scleroderma.
    Pannu J; Gardner H; Shearstone JR; Smith E; Trojanowska M
    Arthritis Rheum; 2006 Sep; 54(9):3011-21. PubMed ID: 16947635
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of granulocyte macrophage-colony stimulating factor on extracellular matrix deposition by dermal fibroblasts from patients with scleroderma.
    Postiglione L; Ladogana P; Montagnani S; di Spigna G; Castaldo C; Turano M; Bruno EM; Di Meglio F; Riccio A; Rossi G
    J Rheumatol; 2005 Apr; 32(4):656-64. PubMed ID: 15801021
    [TBL] [Abstract][Full Text] [Related]  

  • 15. EM703, the new derivative of erythromycin, inhibits transcription of type I collagen in normal and scleroderma fibroblasts.
    Ikeda H; Sunazuka T; Suzuki H; Hamasaki Y; Yamazaki S; Omura S; Hatamochi A
    J Dermatol Sci; 2008 Mar; 49(3):195-205. PubMed ID: 18036782
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-fibroblast antibodies detected by cell-based ELISA in systemic sclerosis enhance the collagenolytic activity and matrix metalloproteinase-1 production in dermal fibroblasts.
    Fineschi S; Cozzi F; Burger D; Dayer JM; Meroni PL; Chizzolini C
    Rheumatology (Oxford); 2007 Dec; 46(12):1779-85. PubMed ID: 17982166
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TGF-β-mediated downregulation of microRNA-196a contributes to the constitutive upregulated type I collagen expression in scleroderma dermal fibroblasts.
    Honda N; Jinnin M; Kajihara I; Makino T; Makino K; Masuguchi S; Fukushima S; Okamoto Y; Hasegawa M; Fujimoto M; Ihn H
    J Immunol; 2012 Apr; 188(7):3323-31. PubMed ID: 22379029
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Imatinib mesylate reduces production of extracellular matrix and prevents development of experimental dermal fibrosis.
    Distler JH; Jüngel A; Huber LC; Schulze-Horsel U; Zwerina J; Gay RE; Michel BA; Hauser T; Schett G; Gay S; Distler O
    Arthritis Rheum; 2007 Jan; 56(1):311-22. PubMed ID: 17195235
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Scleroderma fibroblast phenotype is modulated by endothelial cell co-culture.
    Denton CP; Xu S; Welsh KI; Pearson JD; Black CM
    J Rheumatol; 1996 Apr; 23(4):633-8. PubMed ID: 8730117
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of the immunosuppressant rapamycin on the expression of human α2(I) collagen and matrix metalloproteinase 1 genes in scleroderma dermal fibroblasts.
    Tamaki Z; Asano Y; Kubo M; Ihn H; Tada Y; Sugaya M; Kadono T; Sato S
    J Dermatol Sci; 2014 Jun; 74(3):251-9. PubMed ID: 24630239
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.